Sessions/Tracks

Vascular Dementia 2019  has been planned and implemented in accordance with the accreditation requirementsand policies of the Accreditation Committee

If this educational activity will be accredited with CME and CPD Credits.

Attendance at this meeting will enable you to:

•  
  • Be part of a rich scientific programme incorporating the latest developments in preclinical neurodegenerative diseases like Dementia and Alzheimer's Diseases
  • Understand the shift towards prevention and early diagnosis of neurodegenerative disease as the future of research in the field
  • Join key opinion leaders in discussing regulatory and ethical implications of this research in clinical practice.
  • Network with speakers and other leading experts across disciplines

Session on:

Session 1: Dementia

Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease. Vascular dementia, which occurs after a stroke, is the second most common dementia type. But there are many other conditions that can cause symptoms of dementia, including some that are reversible, such as thyroid problems and vitamin deficiencies. Dementia is a syndrome that involves severe loss of cognitive abilities as a result of disease or injury. Dementia caused by traumatic brain injury is often static, whereas dementia caused by neurodegenerative disorders, such as Alzheimer's disease, is usually progressive and can eventually be fatal. Dementia can be grouped based on the part of brain being affected. it is roughly true that the earliest symptoms in "cortical" dementia include difficulty with high-level behaviors such as memory, language, problem-solving and reasoning; these functions tend to be less impaired in "subcortical" dementia.  Cortical dementia occurs because of damage in the cerebral cortex, the outer layer of the brain. They play a critical role in memory and language. The symptoms usually include severe memory loss. Alzheimer's and Creutzfeldt-Jakob disease are two forms of cortical dementia. Subcortical dementia occurs due to the damage to the part of the brain beneath the cortex. The person suffering from it can show changes in their speed of thinking. Usually, people with subcortical dementia don't have forgetfulness and language problems. Parkinson's disease, Huntington's disease, and HIV are two forms subcortical dementia.

• Mixed dementia
• Frontotemporal dementia
• Neurogenesis in dementia
• Global prevalence of dementia
• Signs and symptoms of dementia
• Primary mental health care and nursing
• Novel therapeutics technology
• Novel therapeutics strategies for Dementia

Session 2: Vascular dementia

Vascular dementia is the broad term for dementia associated with problems of circulation of blood to the brain. There are a number of different types of Vascular dementia. Two of the most common are Multi-infarct dementia and Binswanger's disease. The multi-infarct dementia (MID) and vascular intellectual impedance is dementia caused by issues in the supply of blood to the mind, normally a progression of minor strokes. People with vascular dementiagive dynamic subjective hindrance, intensely or sub acutely as in mellow psychological debilitation, every now and again step-wise, after various cerebrovascular occasions (strokes). A few people may seem to enhance amongst occasions and decrease after more noiseless strokes. A quickly decaying condition may prompt demise from a stroke, coronary illness, or infection. Vascular dementia can be caused by ischemic or hemorrhagic infarcts influencing numerous mind regions, including the foremost cerebral supply route domain, the parietal projections, or the cingulate gurus.

• Vascular dementia prognosis
• Young onset dementia
• Multi-infarct dementia
• Parkinson dementia
• Advences in vascular dementia therapy

Sessiom 3: Lewy body Dementia

Lewy body is also known as dementia with Lewy bodies, with Lewy body dementia is the second most common type of progressive dementia after Alzheimer's disease dementia. Protein deposits, called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement (motor control).

Lewy body dementia is also causes a progressive decline in mental abilities. The people with Lewy body dementiamay experience visual hallucinations and changes in the alertness and attention and other effects include Parkinson's disease-like symptoms such as rigid muscles, slow movement and tremors.

• Risk factor of vascular dementia
• Antipsychotic medications
• Antipsychotic medications
• Palliative care in vascular dementia
• Autophagy
• Synucleinopathies

Session 4: Amyloid Imaging in Dementia

Amyloid imaging is a technique performed in nuclear medicine. It uses PET ligands that allow in vivo detection of amyloid plaques, a core pathologic feature of Alzheimer disease  and dementia.

• Cerebral amyloid angiopathy
• Normal pressure hydrocephalus
• FDG-PET
• Amyloid Immunotherapy
• Beta amyloid protein

Session 5: Alzheimers Disease

Alzheimer's disease (AD) is the most common form of dementia among older people. Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. AD begins slowly. It first involves the parts of the brain that control thought, memory and language. People with AD may have trouble remembering things that happened recently or names of people they know. A related problem, mild cognitive impairment (MCI), causes more memory problems than normal for people of the same age. Many, but not all, people with MCI will develop AD.

• Stages of alzheimers
• Diagnosis of alzheimers
• Risk factors of alzheimers
• Clinical studies of alzheimers
• Treatments of alzheimers

Session 6: Neurodegenerative Diseases

Degenerative nerve diseases affect many of your body's activities, such as balance, movement, talking, breathing, and heart function. Many of these diseases are genetic. Sometimes the cause is a medical condition such as alcoholism, a tumor, or a stroke. Other causes may include toxins, chemicals, and viruses. Sometimes the cause is not known.

• Stroke
• Brain Injury
• Traumatic brain injury: TBI
• Parkinson’s disease (PD) and PD-related disorders
• Prion disease
• Motor neurone diseases (MND)
• Htington’s disease (HD)
• Spinocerebellar ataxia (SCA)
• Spinal muscular atrophy (SMA)

Session 7: Brain diseases

Brain Diseases come in different forms of Infections, trauma, stroke, seizures, and tumors are some of the major categories of brain diseases. Here's an overview of various diseases of the brain

• Migraine
• Attention deficit hyperactivity disorder
• Motor neuron disease
• Bipolar disorder
• Arteriovenous malformation.
• Encephalitis
• Seizures
• Trauma
• Brain abscess

Session 8: Ageing and Dementia

Almost 42% of people over the age of 64 experience some form of memory loss. When there is no underlying medical condition causing this memory loss, it is known as "age-associated memory impairment," which is considered a part of the normal aging process.

• Neuro-anatomical changes in ageing
• Risk factors of cognitive decline
• Granulovacuolar degeneration
• Changes in cerebral cortical microvasculature
• Advances of research in ageing and dementia

Session 9: Dementia Care Management

The developing number of Dementia patients prompts both approach, monetary and wellbeing association imperatives. Numerous social insurance frameworks have created case administration programs with a specific end goal to advance Alzheimer's patients and guardians care and administrations conveyance. Treatment of dementia relies on upon its cause. On account of most dynamic dementia, including Alzheimer's disease there is no cure and no treatment that moderates or stops its movement. In any case, there are medicating medicines that may briefly enhance side effects. Similar pharmaceuticals used to treat Alzheimer's are among the medications once in a while endorsed to help with side effects of different sorts of dementia. Non-sedate treatments can likewise reduce a few manifestations of Dementia. The increasing number of cognitively impaired older adults who exhibit wandering tendencies raises safety concerns. The purpose of the current study in neurology was to research the State-of the-Art in wearable technologies for persons with Alzheimer's disease and identify challenges unique to this population and lessons learned. Inclusion criteria specified systems that completed laboratory testing and were commercially available for usage by community-based Alzheimer's family caregivers.

• Advances in dementia care management
• Dementia care management program
• Undernutrition and obesity in dementia
• Advance care planning

Session 10: Dementia Nursing

People with vascular dementia have different mental element shortfalls that incorporate every memory hindrance, that influences the adaptability to discover new data or review data already learned, and one or extra of the ensuing side effects aphasia, apraxia, agnosia, or official brokenness to such an extent that the mental element shortages adversely affect social or action working with a major decrease in past abilities. Furthermore, people with dementiacommonly experience the ill effects of comorbid conditions that extra confuse mind and block best results. Along these lines, creating caregiving techniques individuals with vascular dementia is pressing, given this expanding commonness and consequently the related weight that dementia places not just on the people, however on the parental figures, relations, and thusly the assets of the human services framework. Traditional perspectives bearing on geriatric nursing ordinarily paint a picture of the care as being moderate paced certain and less requesting than intense care. Be that as it may, care of the matured, and especially those with vascular dementia, is normally confounded, unusual, and flimsy.

• Dementia nursing care plan
• Music therapy in dementia
• Physiotherapy for dementia
• Clinical features of dementia
• Therapeutic interventions in dementia

Session 11: Treating Dementia

Early discovery and exact analysis are critical, as vascular dementia is at any rate halfway preventable .Ischemicchanges in the cerebrum are irreversible, however the patient with vascular dementia can exhibit times of solidness or even gentle change. Since stroke is a basic piece of vascular dementia, the objective is to forestall new strokes. This is endeavored through decrease of stroke chance components, for example, hypertension, high blood lipid levels, atrial fibrillation, or diabetes mellitus. Meta-examinations have discovered that meds for hypertensionare viable at counteractive action of pre-stroke dementia, which implies that hypertension treatment ought to be begun early .These drugs incorporate angiotensin changing over protein inhibitors, diuretics, calcium channel blockers, thoughtful nerve inhibitors, angiotensin II receptor opponents or adrenergic foes. Raised lipid levels, including HDL, were found to expand danger of vascular dementia. Ibuprofen is a medicine that is ordinarily recommended for counteractive action of strokes and heart assaults; it is likewise every now and again given to patients with dementia.

• Psychopharmacological treatment
• Psychopharmacological treatment
• Advanced drugs for dementia
• Cognitive behavioral therapy
• Family therapy in nursing

Session 12: Neuropharmacology

Neuropharmacology is an extremely wide locale of science that includes numerous parts of the sensory system from single neuron control to whole ranges of the cerebrum, spinal line, and fringe nerves. To better comprehend the premise behind medication advancement, one should first see how neurons speak with each other. This article will concentrate on both behavioral and atomic neuropharmacology; the real receptors, particle channels, and neurotransmitters controlled through medication activity and how individuals with a neurological issue advantage from this medication activity.

• Neuroscience and neuropharmacology
• Neurochemical interaction
• Molecular neuropharmacology
• Behavioral neuropharmacology
• Advance research in neuropharmacology

Session 13: Novel therapeutics

Novel therapeutics is a standout amongst the most energizing uses of data preparing frameworks is in diagnostics and treatment. This is not astonishing, given that illness analysis is in its center a data handling undertaking that finishes with a choice. In numerous infections, the conclusion can be performed in singular cells.

• Novel therapeutics strategies for Dementia
• Novel therapeutics technology
• Novel therapeutics molecule
• Anti-dementia drugs
• Novel drug target for the treatment of dementia

Session 14: Animal Models in Dementia

The animal models of dementia  and Alzheimer's disease for pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.

• Animal models of human cognitive aging
• Genetics of translational models
• Protein-protein interactions
• Pre-clinical testing and clinical translation
• Neurobehavioral Toxicology Testing